Production of Lentivirus particles pseudotyped with SARS-CoV-2 spike protein for neutralisation or drug antiviral activity assays. (2023). One Health & Risk Management , 77. https://www.ojs.maxaccs.ie/index.php/journal-ohrm-bba-md/article/view/657